Microbicide Trials Network

MTN-026

A Phase I study that will evaluate whether a gel containing dapivirine is safe for use in the rectum. The study will help determine whether further testing on the safety and acceptability of dapivirine gel as a potential rectal microbicide can be conducted in a larger population.

 

See

MTN-026 Backgrounder

30-October-2017

  

MTN-026 Q&A

30-October-2017

 

See Also

MTN-026 Protocol